The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 17, 2019

Filed:

Nov. 17, 2016
Applicant:

Zymeworks Inc., Vancouver, CA;

Inventors:

Surjit Bhimarao Dixit, Richmond, CA;

Gordon Yiu Kon NG, Vancouver, CA;

Thomas Spreter Von Kreudenstein, Vancouver, CA;

Assignee:

ZYMEWORKS INC., Vancouver, BC, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/07 (2010.01); C07K 16/46 (2006.01); C07K 16/32 (2006.01); C12P 21/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/46 (2013.01); C07K 16/32 (2013.01); C12P 21/005 (2013.01); C07K 2317/14 (2013.01); C07K 2317/41 (2013.01); C07K 2317/52 (2013.01); C07K 2317/526 (2013.01); C07K 2317/64 (2013.01);
Abstract

The present invention provides a process and methods for producing asymmetric antibodies in a mammalian expression system. The asymmetric antibodies are transiently or stably expressed and in cells that stably express the asymmetric antibody, following a rapid 2-step process of stable pool to clone, a highly pure asymmetric antibody expressing clone can be identified at a success frequency that permits for screening of tens of clones rather than thousands. The asymmetric antibodies are produced at a high titre and with a high level of purity with no contaminating homodimer antibodies following protein A purification with a step yield of near 100%. Typical downstream purification processes employ standard hydrophobic interaction chromatography (HIC) and/or cation exchange (CEX) resins and the antibody is stable within a wide dynamic range of buffer pH (4-8) and within the requirements for manufacturing antibodies for pre-clinical and clinical applications.


Find Patent Forward Citations

Loading…